Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling ...

Researchers are exploring cancer drugs as a potential treatment for Alzheimer's disease, a neurodegenerative disorder with ...

Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...

In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that ...

The European Medicines Agency has granted restricted EU authorization to Eli Lilly’s Alzheimer’s drug Kisunla, reversing an ...